Skip to Content

Terumo Group

News

Showing 1 to 9 of 49

Jan 18

First Patient Treated and Enrolled in Terumo Medical Corporation’s Osprey Iliac IDE Clinical Trial

Jan 18, 2023
Nov 1

New Randomized Controlled Study Published in JAMA Demonstrates the Value of Clinical Decision Support Tools in Preventing Acute Kidney Injury in Patients Undergoing Coronary Angiography

Nov 01, 2022
Sep 17

Terumo Announces Study Results Underscoring Safety and Efficacy of Radial to Peripheral (R2P) Interventions in Treatment of Complex Lower Extremity Peripheral Artery Disease (PAD)

Sep 17, 2022
Jul 8

Terumo Unveils “Terumo’s Purpose” to Enhance Joint Value Creation with Diverse Stakeholders

Jul 08, 2022
Mar 31

Terumo Launches New ‘Terumo Medical Care Solutions’ Brand

Mar 31, 2022
Feb 25

Corazon and Terumo Sign Collaboration and Co-Marketing Agreement

Feb 25, 2022
Jan 11

Terumo Medical Corporation Applauds ACC/AHA/SCAI Decision to Designate Radial Access Class 1, Level of Evidence A

Jan 11, 2022
Dec 16

Terumo Announces 5-Year Growth Strategy (GS26) to Deliver Solutions to 21st Century Healthcare Challenges

Dec 16, 2021
Sep 17

Terumo Celebrates 100th Anniversary of Contributing to Society Through Healthcare

Sep 17, 2021

Showing 1 to 9 of 49